Drug
Who makes basiliximab?
2 companies list basiliximab as a human prescription drug, including under the names Simulect. Forms: injection, powder, for solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing basiliximab
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Novartis Pharmaceuticals CorporationSwitzerland | injection, powder, for solution | BLABLA103764 | 2 | 20 |
| Novartis Pharma Stein AG | injection, powder, for solution | DRUG FOR FURTHER PROCESSING | 1 | 0 |
Bulk ingredient listings
- Novartis Pharmaceuticals CorporationSwitzerland · 1 NDC
Enquiry
Common questions
- Who makes basiliximab?
- 2 companies list basiliximab as a human prescription drug in the openFDA NDC Directory, led by Novartis Pharmaceuticals Corporation, Novartis Pharma Stein AG. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies basiliximab active ingredient?
- 1 company lists basiliximab as a bulk ingredient, including Novartis Pharmaceuticals Corporation.